
USFDA APPLICATION NUMBER - 22260 / DOSAGE - INJECTABLE;INJECTION - EQ 0.5MG BASE/VIAL
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| epoprostenol sodium(UNII: 4K04IQ1OF4) (epoprostenol - UNII:DCR9Z582X0) | epoprostenol sodium | 15000ng in 10 |
Inactive Ingredients
| Ingredient Name | Actelion Pharmaceuticals US, Inc. | Jubilant HollisterStier General Partnership | Sun Pharmaceutical Industries, Inc. | Teva Parenteral Medicines, Inc. |
|---|---|---|---|---|
| arginine(94ZLA3W45F) | ||||
| GLYCINE(TE7660XO1C) | ||||
| MANNITOL(3OWL53L36A) | ||||
| SODIUM CHLORIDE(451W47IQ8X) | ||||
| SODIUM HYDROXIDE(55X04QC32I) | ||||
| SUCROSE(C151H8M554) |